Development of a vaccine incorporating killed virus of canine origin for the prevention of canine parvovirus infection.
A parvovirus of canine origin, cultured in a feline kidney cell line, was inactivated with formalin. Three pilot serials were produced and three forms of finished vaccine (nonadjuvanted, single adjuvanted and double adjuvanted) were tested in vaccination and challenge trials. A comparison was also made with two inactivated feline panleukopenia virus vaccines, one of which has official approval for use in dogs. The inactivated canine vaccine in nonadjuvanted, adjuvanted or double adjuvanted form was immunogenic in 20 of 20 vaccinated dogs. The double adjuvanted vaccine is selected as the one of choice on the basis of best and most persistent seriological response.
D000818:Animals; D002986:Clinical Trials as Topic; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs; D010321:Parvoviridae / Q000276:immunology*; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D014777:Virus Diseases / Q000517:prevention & control / Q000662:veterinary*
D014613:Vaccines, Attenuated; D014765:Viral Vaccines